Abstract:Objective To study the clinical features of post-renal transplantation diabetes mellitus(PTDM) and improve its prevention and treatment.Methods Twenty-eight patients with PTDM were retrospectively reviewed.The general condition,blood glucose,glycosylated hemoglobin(HbA1c),blood cyclosporine A trough level(CsA Co),serum lipid,islet function and islet antibodies were detected and the results were compared with those of 30 patients with type 2 diabetes mellitus(T2DM) and matched DM duration.Results ① The renal transplantation history,median of PTDM history and median interval from transplantation to onset of PTDM were(5.5±4.7) years,0.8 years(2 d-7 years) and 2.3 years( years),respectively.Ten cases had the diabetic symptoms while 14 cases had family history of DM.② Compared with T2DM patients with matched diabetic duration,patients of PTDM had higher incidence of hypertension(82.1% vs.53.3%,P=0.019).PTDM patients had earlier onset than T2DM patients( years vs. years,P=0.001).The total cholesterol([5.57±1.53] vs.[4.45±1.18] mmo/L,P=0.003),triglyceride([2.51±1.55] vs.[1.82±0.68] mmo/L,P=0.037),apolipoprotein E([67.72±18.24] vs.[50.68±11.61] mg/L,P=0.001) and high-density lipoprotein cholesterol([1.33±0.46] vs.[0.93±0.28] mmo/L,P=0.02) in PTDM patients were significantly higher than those in the T2MD patients.Postprandial C-peptide was lower([1 394.96±835.81] vs.[2 399.71±1 513.56] pmol/L,P=0.004).More patients of PTDM had DM family history(50% vs.20%,P=0.016) and received insulin therapy(67.86% vs.36.67%,P=0.018).There were no significant difference in body mass index(BMI),apolipoprotein AI,apolipoprotein B,lipoprotein a,low-density lipoprotein cholesterol and fasting C-peptide between the 2 groups.③ Positive islet antibodies were found in 2 PTDM patients.④ There was no correlation between fasting blood glucose and CsA Co,either was HbA1c(both P>0.05).Conclusion PTDM is a serious complication secondary to post-renal transplantation immuno-suppression.Compared with T2DM,patients of PTDM are often asymptomatic and have earlier onset with impaired islet function.PTDM patients have severe dyslipidemia.Blood glucose and serum lipid should be carefully monitored after kidney transplantation.Earlier PTDM diagnosis and appropriate treatment are beneficial to reverse glucose and lipid disorder.

Prevalence and Long-Term Glucose Metabolism Evolution of Post-Transplant Diabetes Mellitus in Chinese Renal Recipients

Influence of duration of type 1 diabetes on long-term pancreatic transplant outcomes.

Influence of Dialysis Duration on Outcomes of Simultaneous Pancreas-Kidney Transplant

Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: the impact of pre-existing diabetes mellitus.

An Analysis on the Prevalence and Risk Factors of Post-Transplant Diabetes Mellitus after Renal Transplantation

Establishment and validation of a predictive model for post-transplantation diabetes mellitus based on glucose status on day 3 after kidney transplantation

Analysis of risk factors and establishment of a risk prediction model for post-transplant diabetes mellitus after kidney transplantation

Analysis of risk factors for post-transplant diabetes mellitus in patients with renal transplants

The Effect of Posttransplantation Diabetes Mellitus on the Prognosis of Transplantation: a Prospective Cohort Study

Post-Transplant Diabetes Mellitus in Kidney-Transplanted Patients: Related Factors and Impact on Long-Term Outcome

Analysis of Risk Factors for Post-Transplant Diabetes Mellitus after Kidney Transplantation

Analysis on the Changing Trend of Fasting Plasma Glucose and Its Impact on Prognosis after Renal Transplantation

Patient survival after renal transplantation: IV. Impact of post-transplant diabetes

Study on risk factors for new onset diabetes mellitus post orthotopic heart transplant (PTDM) and the relationship between PTDM and long-term survival

[The Characteristics and Risk Factors for Post-Transplantation Diabetes Mellitus].

Clinical features of post-renal transplantation diabetes mellitus:an analysis of 28 cases

The Incidence of Posttransplantation Diabetes Mellitus During Follow-Up in Kidney Transplant Recipients and Relationship to Fok1 Vitamin D Receptor Polymorphism

Predictive factors associated with reversibility of post-transplantation diabetes mellitus for adult: a Meta-analysis

Perioperative glucose monitoring with continuous glucose monitors identifies risk factors for post-transplant diabetes mellitus in kidney transplant recipients

Post-transplantation diabetes in kidney transplant recipients: an update on management and prevention

Prevalence of abnormal glucose metabolism and preliminary investigation of its pathogenesis in patients being alive over 3 years after liver transplantation